Search - tctmd.com

Displaying 101 - 120 of 166

Sort: Relevancy | Date

News Daily News

TAVR 后心肌损伤与死亡率挂钩

Caitlin E. Cox

November 02, 2015

News Daily News

Post-TAVR Myocardial Injury Linked to Mortality

Caitlin E. Cox

November 02, 2015

News Daily News

Las Lesiones Miocárdica Post-TAVR se asocian a la Mortalidad

Caitlin E. Cox

November 02, 2015

Presentation TCT 2015

FDA-Approved or US IDE Studies: LOTUS Procedural Considerations and Case Examples

Presenter: Ariel Finkelstein, Ganesh Manoharan, Ted E. Feldman

October 14, 2015

News Industry News

Boston Scientific Announces Scheduled Presentations At TCT 2015

October 08, 2015

News Industry News

Boston Scientific Announces Additional Investment And Right To Acquire MValve Technologies

October 08, 2015

News Industry News

MValve Technologies Implants First Human Catheter Based Mitral Valve Replacement System

October 05, 2015

Presentation CICT 2015

The Lotus Valve: A Case Study and Evidence Update

Presenter: Ted Feldman

August 01, 2015

News Industry News

Boston Scientific Announces CE Mark And FDA Clearance For Safari2 ™ Pre-Shaped Guidewire

July 22, 2015

News Daily News

在一项单中心、非随机研究中，Lotus瓣膜的一些指标超过CoreValve

L.A. McKeown

June 17, 2015

News Daily News

Lotus Valve Tops CoreValve on Some Measures in Single-Center, Nonrandomized Study

L.A. McKeown

June 17, 2015

News Daily News

La Válvula Lotus Supera a la CoreValve en Algunos Indicadores en un Estudio No Aleatorizado de un Único Centro

L.A. McKeown

June 17, 2015

Presentation TVT 2015

CT Sizing for Other New TAVR Systems: Roundtable Discussion - Lotus Valve

Presenter: Ian T. Meredith

June 05, 2015

News Industry News

Post-Market Study Evaluating The Boston Scientific Lotus™ Valve System Demonstrates Extremely Low PVL Rates

May 20, 2015

News Daily News

采用Sapien 3经股动脉植入时，死亡率和卒中发生率均很低

December 04, 2014

News Daily News

Low Mortality, Stroke With Transfemoral Implant of Sapien 3

December 04, 2014

News Daily News

Bajo Índice de Mortalidad y ACV con el Implante Transfemoral de Sapien 3

December 04, 2014

News Industry News

Boston Scientific Enrolls First Patients In U.S. Trial Of The Lotus™ Valve System

September 23, 2014

Presentation TCT 2014

TCT 696: One-Year Outcomes with the Fully Repositionable and Retrievable Lotus? Transcatheter Aortic Replacement Valve in 120 High-Risk Surgical Patients with Severe Aortic Stenosis: Results from the REPRISE II CE-Mark Study

Presenter: Ian T. Meredith

September 15, 2014

Presentation TCT 2014

Lotus Valve - Technology Review and Status of the US Clinical Trial

Presenter: Ted E. Feldman

September 15, 2014

Advertisement

TAVR 后心肌损伤与死亡率挂钩

Post-TAVR Myocardial Injury Linked to Mortality

Las Lesiones Miocárdica Post-TAVR se asocian a la Mortalidad

FDA-Approved or US IDE Studies: LOTUS Procedural Considerations and Case Examples

Boston Scientific Announces Scheduled Presentations At TCT 2015

Boston Scientific Announces Additional Investment And Right To Acquire MValve Technologies

MValve Technologies Implants First Human Catheter Based Mitral Valve Replacement System

The Lotus Valve: A Case Study and Evidence Update

Boston Scientific Announces CE Mark And FDA Clearance For Safari2 ™ Pre-Shaped Guidewire

在一项单中心、非随机研究中，Lotus瓣膜的一些指标超过CoreValve

Lotus Valve Tops CoreValve on Some Measures in Single-Center, Nonrandomized Study

La Válvula Lotus Supera a la CoreValve en Algunos Indicadores en un Estudio No Aleatorizado de un Único Centro

CT Sizing for Other New TAVR Systems: Roundtable Discussion - Lotus Valve

Post-Market Study Evaluating The Boston Scientific Lotus™ Valve System Demonstrates Extremely Low PVL Rates

采用Sapien 3经股动脉植入时，死亡率和卒中发生率均很低

Low Mortality, Stroke With Transfemoral Implant of Sapien 3

Bajo Índice de Mortalidad y ACV con el Implante Transfemoral de Sapien 3

Boston Scientific Enrolls First Patients In U.S. Trial Of The Lotus™ Valve System

TCT 696: One-Year Outcomes with the Fully Repositionable and Retrievable Lotus? Transcatheter Aortic Replacement Valve in 120 High-Risk Surgical Patients with Severe Aortic Stenosis: Results from the REPRISE II CE-Mark Study

Lotus Valve - Technology Review and Status of the US Clinical Trial

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content